Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP KFPs / SAQsmetabolic-and-endocrine-health

GP KFPs / SAQs · metabolic-and-endocrine-health

Type 2 diabetes — KFP-style written assessment

KFP-style staged scenarios on type 2 diabetes in general practice: confirming diagnosis, comorbidity-driven second-agent selection, the hyperosmolar emergency, insulin initiation, and the remission conversation.

30 marks45 min3 min readVerification in progress

Target exams

RACGP KFPRACGP AKTMRCGP AKT
On this page
Study tools

Target exams

RACGP KFPRACGP AKTMRCGP AKT
Prompt
Type 2 diabetes: comorbidity before the number — diagnosis, escalation, emergencies and remission

KFP 1 (10 marks)

A 57-year-old man with BMI 32 kg/m² and hypertension was found on two occasions to have HbA1c 55 mmol/mol (7.2%) and fasting glucose 7.8 mmol/L. He is asymptomatic, walks daily, and asks whether he can "just watch his diet". His father lost a leg to diabetes. [1]

  1. Confirm or refute the diagnosis with the criteria you would apply, and state what his single-test status would have required had only one result been abnormal. (3) [1]
  2. Justify starting metformin now rather than diet alone, citing the specific trial evidence. (4) [2]
  3. Outline the annual complication surveillance you will schedule from today. (3) [3]

Model answers

  1. The diagnosis is confirmed: HbA1c 55 mmol/mol exceeds the 48 mmol/mol (6.5%) threshold and fasting glucose 7.8 mmol/L exceeds 7.0 mmol/L — two abnormal results from the same or separate samples suffice in an asymptomatic patient. Had only one test been abnormal, confirmation with a second abnormal result (repeat HbA1c, fasting glucose or OGTT) would be required before labelling. [1]
  2. UKPDS 34 randomised overweight patients with newly diagnosed type 2 diabetes to metformin or conventional diet therapy over a median 10.7 years: metformin reduced any diabetes-related endpoint by 32% (95% CI 13–47), diabetes-related death by 42%, and all-cause mortality by 36% — benefits diet alone did not deliver. His family history of diabetic complications strengthens the case for immediate pharmacotherapy alongside lifestyle change. [2]
  3. Annual cycle: dilated retinal photography; urine albumin-to-creatinine ratio and eGFR; foot examination with 10 g monofilament and pulse assessment; blood pressure, lipids, weight and smoking review; influenza and pneumococcal vaccination status; and structured hypoglycaemia/driving advice whenever regimens change. [3]
General Practice Pro

Continue reading

You have read the opening of this kfps / saq. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]American Diabetes Association Professional Practice Committee 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025 Diabetes Care, 2025.PMID 39651986
  2. [2]UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet, 1998.PMID 9742977
  3. [3]Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia, 2022.PMID 36151309
  4. [4]Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy N Engl J Med, 2019.PMID 30990260
  5. [5]Pasquel FJ, Umpierrez GE Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment Diabetes Care, 2014.PMID 25342831
  6. [6]Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial Lancet, 2018.PMID 29221645
  7. [7]Lasserson DS, Glasziou P, Perera R, et al. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses Diabetologia, 2009.PMID 19644668
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousOsteoporosis — KFP-style written assessmentmetabolic-and-endocrine-healthNextPalliative symptom control in the community — KFP-style written assessmentpalliative-care